You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 17, Issue 3

March 2024 - 138 articles

Cover Story: This review highlights the substantial benefit that peptide receptor radionuclide therapy (PRRT) with an α-emitting radionuclide may offer patients with neuroendocrine tumors (NETs). The radiobiological basis for using α-emitters, based on their high linear energy transfer and short range, was discussed. Candidate α-emitters were critically evaluated. The current published literature for targeted alpha therapy of NETs was reviewed, from in vitro to clinical experience, showing a response rate far exceeding that expected from β-PRRT. Despite promising results, studies are heterogeneous, and treatment is non-optimized. It is hoped that theragnostic imaging and dosimetry will aid in understanding the relationships between activity, absorbed dose, therapeutic response, and toxicity to facilitate this optimization for future patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (138)

  • Communication
  • Open Access
12 Citations
4,458 Views
6 Pages

17 March 2024

Antimicrobial resistance is a major global health issue. Metallo-β-lactamases (MBL), in particular, are problematic because they can inactivate all classes of β-lactams except aztreonam. Unfortunately, the latter may be simultaneously inact...

  • Article
  • Open Access
16 Citations
4,397 Views
16 Pages

17 March 2024

Machine learning techniques are extensively employed in drug discovery, with a significant focus on developing QSAR models that interpret the structural information of potential drugs. In this study, the pre-trained natural language processing (NLP)...

  • Article
  • Open Access
2 Citations
3,267 Views
22 Pages

17 March 2024

Notch ligands and receptors are important for cell specification and angiogenesis, but their role in oxygen-induced retinopathy (OIR) is not well studied. Delta-like ligand (DLL)-4/Notch inhibits angiogenesis, while Jagged-1/Notch promotes angiogenes...

  • Article
  • Open Access
2 Citations
2,889 Views
15 Pages

The Association between Molecular Initiating Events and Drug-Induced Hiccups

  • Ryuichiro Hosoya,
  • Reiko Ishii-Nozawa,
  • Tomoko Terajima,
  • Hajime Kagaya and
  • Yoshihiro Uesawa

16 March 2024

Hiccups can significantly reduce the quality of life of patients and can occur as a drug side effect. Previous reports have revealed sex-specific differences in the incidence of drug-induced hiccups. However, the pathogenesis of drug-induced hiccups...

  • Article
  • Open Access
6 Citations
5,751 Views
16 Pages

16 March 2024

Empirically, in Indonesia, the leaves of Cassia alata L. (candle bush or ketepeng cina) have been used as a topical antifungal agent. Malassezia furfur is a natural microorganism found in the human body. It is among the factors contributing to condit...

  • Article
  • Open Access
5 Citations
2,407 Views
14 Pages

15 March 2024

Angelicae pubescentis radix (APR) has been traditionally used for thousands of years in China to treat rheumatoid arthritis (RA), an autoimmune disorder. As the main active coumarin of APR, columbianadin (CBN) exhibits a significant anti-inflammatory...

  • Article
  • Open Access
10 Citations
2,707 Views
15 Pages

Synthesis, Computational Study, and In Vitro α-Glucosidase Inhibitory Action of 1,3,4-Thiadiazole Derivatives of 3-Aminopyridin-2(1H)-ones

  • Zarina Shulgau,
  • Irina V. Palamarchuk,
  • Shynggys Sergazy,
  • Assel Urazbayeva,
  • Yerlan Ramankulov and
  • Ivan V. Kulakov

15 March 2024

This article reports on the synthesis of nine promising new 1,3,4-thiadiazole derivatives based on 3-aminopyridones, containing various acidic linkers. The synthesis was carried out by cyclizing the corresponding thiohydrazides 4a–c and anhydri...

  • Article
  • Open Access
2 Citations
1,892 Views
16 Pages

New Pyrazolyl Thioureas Active against the Staphylococcus Genus

  • Anna Maria Schito,
  • Debora Caviglia,
  • Susanna Penco,
  • Andrea Spallarossa,
  • Elena Cichero,
  • Bruno Tasso and
  • Chiara Brullo

15 March 2024

To meet the urgent need for new antibacterial molecules, a small library of pyrazolyl thioureas (PTUs) was designed, synthesized and tested against difficult-to-treat human pathogens. The prepared derivatives are characterized by a carboxyethyl funct...

  • Article
  • Open Access
2,773 Views
14 Pages

Small-Angle X-ray Scattering (SAXS) Used for the Identification of Nicomorphine Polymorphic Changes at the Early Stage to Avoid Varied Stability and Possible Side Effects

  • Nermina Malanovic,
  • Giovanni Birarda,
  • Simone Eder,
  • Heidrun Gruber-Woelfler,
  • Franz Reiter,
  • Krunoslav Juraic and
  • Aden Hodzic

15 March 2024

In this paper, we present the identification of polymorphisms at an early stage, identified by applying non-standard methods such as SAXS. We provide an analytical approach to polymorphism in the quality/purity of an active pharmaceutical ingredient...

  • Article
  • Open Access
11 Citations
3,720 Views
18 Pages

Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus

  • Shatha M. Alobaid,
  • Rahaf M. Alshahrani,
  • Asma S. Alonazi,
  • Nawal M. Alrasheed,
  • Maha A. Alamin,
  • Tahani K. Alshammari,
  • Anfal F. Bin Dayel,
  • Doaa M. Elnagar,
  • Rana R. Alotaibi and
  • Lama A. Almuthnabi
  • + 8 authors

15 March 2024

One of the possible candidates for the treatment of diabetic cardiomyopathy is liraglutide, a glucagon-like peptide-1 receptor (GLP1R) agonist. In this study, the impacts of liraglutide on the integrin-linked kinase (ILK)-related PI3K/AKT axis in rat...

of 14

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247